Search results
Hims & Hers (HIMS) Gains 37.7% in Three Months: What's Next?
Zacks via Yahoo News· 5 hours agoHims & Hers (HIMS) is enhancing its offerings and expanding the breadth of health and wellness...
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is...
People via Yahoo News· 1 day agoWhile some recent reports have highlighted the potential for drugs that are classified as...
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Zacks via Yahoo News· 1 day agoA new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's...
Ozempic is changing the way people eat. Snack companies are paying close attention
CBC via Yahoo News· 2 days agoRaegan Sather says her appetite has completely changed — and so has her approach to grocery shopping...
Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
Zacks via Yahoo News· 2 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
Yahoo Finance· 3 days agoNovo also said that the cost of both of its GLP-1s has decreased 40% since launch. "Unfortunately,...